Skip to content
DataLookout
Menu

NeoDecoNCT05993442

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

Version history last read from ClinicalTrials.gov on Aug 30, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
    • Final enrollment: 1379 participants (planned 3080)
  2. Notable Primary completion date: Sep 2025 to Apr 2026v5 Show 7 more changesShow less
    • Eligibility criteria expanded, about 9 words
    • Primary endpoints: 2 to 1
    • Study sites: 10 to 24
    • Study completion date: Mar 2026 to May 2026
    • Secondary endpoints: 2 to 9
    • Study description expanded, about 126 words
    • Collaborators reordered
  3. Notable Trial status: Not Yet Recruiting to Recruitingv4 Show 8 more changesShow less
    • Enrollment target: 11440 to 3080
    • Primary completion date: Feb 2025 to Sep 2025
    • Study sites: 0 to 10
    • Study completion date: Sep 2026 to Mar 2026
    • Start date changed from estimate of Feb 2024 to May 28, 2024
    • Study description expanded, about 46 words
    • Collaborators: 6 to 7
    • Study title shortened, about 2 words
  4. Notable Primary completion date: Feb 2024 to Feb 2025v3 Show 7 more changesShow less
    • Start date: Nov 2023 to Feb 2024
    • Eligibility criteria expanded, about 23 words
    • Study completion date: Aug 2025 to Sep 2026
    • Interventions: Optimising kangaroo care (Behavioral) to Optimised kangaroo care (Behavioral)
    • Study description shortened, about 59 words
    • Collaborators expanded, about 24 words
    • Study title expanded, about 5 words
  5. Minor Secondary endpoints: details revised at 2 of 2 entriesv2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Neonatal severe infection/sepsis defined as an episode of one of three infectious entities as registered in the surveillance system
Timeframe: 12 months

Secondary (9)

Resistant bacterial colonisation defined as the detection of one or more pre-specified bacterial resistance genes in a stool sample during a PPS
Surveillance-based neonatal severe infection/sepsis based on cluster-aggregated NeoIPC Surveillance data.
Infection outcomes assessed with separate cumulative incidences of the three components of the primary outcome and necrotising enterocolitis
Infection outcomes defined with incidence rate number
Major non-infection neonatal morbidity collected aggregated at the cluster level, separately for the baseline and intervention period, and is therefore a unit-level endpoint
Show 4 moreShow less
Neonatal unit length of stay: total number of calendar days an infant was hospitalised on the neonatal unit during the study period
Antibiotic treatment recording through both NeoIPC Surveillance and clinical data collection in PPS
StSC duration in hours and minutes in the preceding 24 hours
StSC target attainment: the minimum expected target duration of StSC is a site-specific total daily duration of StSC to be provided per infant per day

Arms and interventions

Optimised kangaroo careExperimental

The sites randomised in this group will adapt the study intervention consisting of: Component 1: Skin-to-skin contact for optimised KC, describes the targeted level of early, repeated and sustained skin-to-skin contact (StSC) considered to represent optimised KC in a high-technology neonatal unit environment in which KC is already offered as part of routine care. Component 2: Implementation Support aims to engage clinical staff in the neonatal unit who are involved in implementing StSC as part of optimised KC.

Standard of CareNo intervention

The sites randomised in this group will follow the standard care, including KC and StSC sessions, treatment of severe infections/sepsis and infection prevention and control measures based on current routine local practice. Standard care in all participating NICUs already includes KC but without specific activities to ensure this is implemented according to international best practice recommendations.

Behavioral: Optimised kangaroo care

Sites

24 sites in 5 countries

Greece 7, Switzerland 5, United Kingdom 5, Italy 4, Spain 3